Skip to main content

Galectin Therapeutics Inc

GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001133416

In the last 90 days, Galectin Therapeutics Inc insiders filed 0 open-market purchases and 1 sale; 98 institutions reported holding it in 13F filings for Q2 2026, worth $72.2M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Galectin Therapeutics Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $83.3K in total
Insiders trading
1
Net value
−$83.3K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Galectin Therapeutics Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Galectin Therapeutics Inc
NameTitleLast reported holdingLast filingFilings, past year
Uihlein Richard EDirector, 10% Owner44,713,843IndirectAug 4, 20262
Jamil KhurramChief Medical Officer0Jul 16, 20269
Shlevin Harold H.Director6,500Jun 30, 20265
Brem HenryDirector–Mar 17, 20261
Eldred KaryDirector65,682Feb 9, 20264
Lewis JoelPresident and CEO776,260Jan 22, 20268
Carson Benjamin SrDirector–Jan 21, 20261
Amelio Gilbert FDirector–Jan 21, 20261
Omenn Gilbert SDirector–Jan 21, 20261
Callicutt Jack WChief Financial Officer7,614Jan 21, 20266
Freeman Kevin DDirector55,269Jan 21, 20262
Schwartz Elissa J.Director1,000Jan 21, 20261
Zordani Richard A. Jr.Director42,083Jan 21, 20261
Czirr James C10% Owner5,614,457Dec 18, 20254
10X Fund, L.P.10% Owner5,614,457Dec 18, 20254
10X Capital Management, LLC10% Owner5,614,457Dec 18, 20254
Rubin MarcDirector–Jan 27, 20250
Boudes Pol FChief Medical Officer–Feb 7, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Oct 16, 2024 (view filing)Oct 16Same dayFreeman Kevin DDirectorPPurchase+5.00K$2.70+$13.5K+6.7%80.0K after
Aug 26, 2024 (view filing)Aug 233 daysZordani Richard A. Jr.DirectorPPurchase+1.00K$2.30+$2.30K+100.0%2.00K after
Aug 26, 2024 (view filing)Aug 22-234 daysZordani Richard A. Jr.DirectorPPurchase+2.50K$2.30+$5.75K+8.5%32.1K after2 lots
Jul 23, 2024 (view filing)Jul 221 dayEldred KaryDirectorPPurchase+400$2.39+$956+0.8%49.7K afterAmended
Jun 20, 2024 (view filing)Jun 20Same dayFreeman Kevin DDirectorPPurchase+2.50K$2.38+$5.95K+9.6%28.5K after
Apr 30, 2024 (view filing)Apr 30Same dayZordani Richard A. Jr.DirectorPPurchase+1.00K$3.52+$3.52KNew position1.00K after
Apr 25, 2024 (view filing)Apr 22-233 daysLateCzirr James C10% OwnerSSale−25.0K$3.06−$76.5K−0.4%5.92M after2 lots
Apr 25, 2024 (view filing)Apr 241 dayLewis JoelPresident and CEOPPurchase+1.00K$3.39+$3.39K+100.0%2.00K after
Apr 22, 2024 (view filing)Apr 22Same dayFreeman Kevin DDirectorPPurchase+2.50K$2.98+$7.45K+10.7%26.0K after
Jan 16, 2024 (view filing)Jan 16Same dayEldred KaryDirectorPPurchase+500$1.79+$895+1.0%49.3K after
Jul 20, 2023 (view filing)Jul 191 dayEldred KaryDirectorPPurchase+1.60K$1.79+$2.86K+3.4%48.8K after
Feb 21, 2023 (view filing)Feb 21Same dayEldred KaryDirectorPPurchase+1.00K$1.59+$1.59K+2.2%47.2K after
Feb 21, 2023 (view filing)Feb 165 daysLewis JoelPresident and CEOPPurchase+1.00K$1.52+$1.52KNew position1.00K after
Jan 26, 2023 (view filing)Jan 251 dayEldred KaryDirectorPPurchase+1.30K$1.11+$1.44K+2.9%46.2K after
Nov 17, 2022 (view filing)Nov 17Same dayCallicutt Jack WChief Financial OfficerPPurchase+4.00K$1.32+$5.28K+110.7%7.61K after
Oct 31, 2022 (view filing)Oct 283 daysFreeman Kevin DDirectorPPurchase+10.0K$1.41+$14.1K+15.4%75.0K after
Aug 15, 2022 (view filing)Jul 2719 days10X Fund, L.P.10% OwnerSSale−10.0K$2.09−$20.9K−0.2%6.17M afterAmended
Aug 9, 2022 (view filing)3:01 PM ETJul 2218 daysLateCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$2.09−$20.9K−0.2%6.17M after
Jul 29, 2022 (view filing)Jul 281 dayZordani Richard A. Jr.DirectorPPurchase+5.00K$2.50+$12.5K+20.3%29.6K after
May 20, 2022 (view filing)May 191 dayFreeman Kevin DDirectorPPurchase+5.00K$1.33+$6.65K+8.3%65.0K after
Apr 18, 2022 (view filing)Apr 18Same dayFreeman Kevin DDirectorPPurchase+5.00K$1.71+$8.55K+9.1%60.0K after
Apr 4, 2022 (view filing)Apr 4Same dayZordani Richard A. Jr.DirectorPPurchase+5.00K$1.61+$8.05K+25.5%24.6K after
Feb 4, 2022 (view filing)6:23 PM ETFeb 22 daysCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$2.10−$21.0K−0.2%6.18M after
Jan 24, 2022 (view filing)Jan 213 daysSchwartz Elissa J.DirectorPPurchase+1.00K$2.00+$2.00KNew position1.00K after
Jan 19, 2022 (view filing)Jan 19Same dayFreeman Kevin DDirectorPPurchase+5.00K$1.96+$9.80K+10.0%55.0K afterAmended
Jan 18, 2022 (view filing)Jan 144 daysZordani Richard A. Jr.DirectorPPurchase+5.00K$2.02+$10.1K+34.3%19.6K after
Jan 13, 2022 (view filing)3:42 PM ETJan 112 daysCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$2.10−$21.0K−0.2%6.19M after
Dec 15, 2021 (view filing)Dec 15Same dayFreeman Kevin DDirectorPPurchase+5.00K$2.28+$11.4K+11.1%50.0K afterAmended
Dec 6, 2021 (view filing)12:42 PM ETDec 24 daysCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$2.37−$23.7K−0.2%6.20M after
Dec 6, 2021 (view filing)Dec 6Same dayFreeman Kevin DDirectorPPurchase+5.00K$2.34+$11.7K+12.5%45.0K after
Nov 4, 2021 (view filing)11:55 AM ETNov 13 daysLateCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$3.19−$31.9K−0.2%6.21M after
Nov 1, 2021 (view filing)Oct 293 daysFreeman Kevin DDirectorPPurchase+2.00K$3.17+$6.34K+5.3%40.0K after
Oct 21, 2021 (view filing)Oct 21Same dayFreeman Kevin DDirectorPPurchase+2.00K$3.19+$6.38K+5.6%38.0K after
Oct 19, 2021 (view filing)3:18 PM ETOct 154 daysCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$3.37−$33.7K−0.2%6.22M after
Oct 19, 2021 (view filing)Oct 19Same dayFreeman Kevin DDirectorPPurchase+3.00K$3.37+$10.1K+9.1%36.0K after
Oct 6, 2021 (view filing)12:00 PM ETOct 42 daysCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$3.62−$36.2K−0.2%6.23M after
Sep 23, 2021 (view filing)Sep 23Same dayFreeman Kevin DDirectorPPurchase+3.00K$3.88+$11.6K+10.0%33.0K after
Sep 3, 2021 (view filing)9:00 AM ETSep 12 daysCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$3.91−$39.1K−0.2%6.24M after
Aug 3, 2021 (view filing)3:48 PM ETAug 21 dayCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$3.25−$32.5K−0.2%6.25M after
Jul 15, 2021 (view filing)2:27 PM ETJul 96 daysLateCzirr James C and 2 othersDirector, 10% OwnerSSale−10.0K$3.54−$35.4K−0.2%6.26M after